For women with opioid use disorder (OUD) during pregnancy, medication-assisted treatment (MAT) is currently the standard of care. However, few studies examine the longitudinal impacts of MAT for OUD as it relates to the mother-child dyad, and specifically child custody placement and long-term maternal adherence to treatment regimens postpartum. The purpose of this study is to describe the rates and predictors of maternal retention in treatment following delivery, as well as the predictors of child custody retention postpartum.

This retrospective cohort study will utilize recovery data from the Oklahoma Department of Mental Health and Substance Abuse Services (ODMHSAS), service logs from the Substance Use, Treatment, and Recovery (STAR) Prenatal Clinic mABC study participants, and Department of Human Services (DHS) data to answer these questions. Specifically, this study will examine outcomes between November 2019 and January 2023 to assess retention rates at delivery discharge, 1 month postpartum, 6 months postpartum, 12 months postpartum, and 24 months postpartum.

This study is currently ongoing.